© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 30.47% of NERV shares are held by financial institutions. BLACKROCK INC. is the top corporate investor, holding 72.67K shares valued at $187.49K. A 0.96% stake in Minerva Neurosciences, Inc. is owned by the company. FEDERATED HERMES, INC. owns 1.35M shares valued at $3.49M, which translates its holding of 17.85% of the stake in the company.
Among the NERV insiders holding of 22.26% of the stake in company, DE RUBERTIS FRANCESCO, , holds the largest shares of 4.49M. OLLIER MICHELE, , is the second largest NERV insider with ownership of 4.49M shares. INDEX VENTURE ASSOCIATES III LTD, 10 percent owner, stands third with possession of 3.9M shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NERV shares is 25, representing 30.47% of the company's common stock.
NORTHERN TRUST CORP, in the last quarter, reduced its stake in NERV by -7.6% restricting it's holding to 23.09 thousand shares of worth nearly $59.56K. BANK OF AMERICA CORP /DE/ also lessened -2.34% of the NERV shares from its portfolio, reducing its holding to 125 shares of worth $322.00. UBS GROUP AG also shunned NERV shares holding by -84.62% last quarter which brought its holding to 10 shares worth $26.00.
As per its latest 13F filing, VANGUARD GROUP INC increased its stake in NERV by 22.86% in the last quarter. The institutional holder raised its holding to 252.06 thousand shares having worth more than $650.32K. RENAISSANCE TECHNOLOGIES LLC also added 65.83% more shares of NERV to its portfolio, raising its holding to 177.77 thousand shares of worth $459.00K. UBS OCONNOR LLC also increased its NERV shares holding by 54.14% which brought its holding to 99.64 thousand shares worth $257.08K.
The insider with the most stakes in NERV is De Rubertis Francesco , at the company. Additionally, NERV stock is highly held by Ollier Michele and 10 percent owner Index Venture Associates III Ltd among others.
Company executives, directors, and other insiders own 22.26% percent of Minerva Neurosciences, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which NERV insiders have sold stock, totaling 0 shares. Insiders that have sold shares include LUTHRINGER REMY, AHLHOLM FREDERICK W, and RACE GEOFF.
There have been 0 transaction(s) during the past 6-months in which Minerva Neurosciences, Inc. insiders have bought stock, totalling 0 shares
Around 0 Minerva Neurosciences, Inc. shares are held by insiders, which represents about 22.26% of NERV stock.
NERV , De Rubertis Francesco holds the largest portfolio of the company's shares. NERV shares owned by De total nearly 4.49 million.
BLACKROCK INC. is the largest institutional owner in NERV which holds 72.67 thousand shares worth $187.49K or 0.96% of the total NERV shares outstanding followed by FEDERATED HERMES, INC. with ownership of 1.35 million shares representing 17.85% of the NERV ownership. VANGUARD GROUP INC is the third largest stakeholder with 252.06 thousand shares or 3.33% of the ownership worth more than $650.32K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NERV is concerned, it is a stock which is not optionable.
Number of NERV shares short is 14.83K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 6.99M shares of NERV are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NERV has 5.44M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NERV is 0.39.